http://www.exelixis.com
Exelixis, Inc. Company Intro
We drive to deliver results and new medicines to treat and defeat cancer, giving patients hope for the future. Cancer is our cause.
Industry
Healthcare
Exelixis, Inc. Headquaters
1851 Harbor Bay Parkway
Alameda,94502
United States
Exelixis, Inc. Share price
17 May 2023 13:09 GMT
$19.23
-0.27 (-1.38 %)
Exelixis, Inc. Market cap
$6.229 B
WMC RANKING
2024
Exelixis, Inc. # 15
BiotechnologyLatest Exelixis, Inc. News
12 Feb 2024
Massachusetts Financial Services Co. MA Sells 3667 Shares of Exelixis, Inc. (NASDAQ:EXEL)
Read Massachusetts Financial Services Co. MA Sells 3667 Shares of Exelixis, Inc. (NASDAQ:EXEL) at Defense World.
12 Feb 2024
Exelixis, Inc. (NASDAQ:EXEL) Shares Acquired by Swiss National Bank
Read Exelixis, Inc. (NASDAQ:EXEL) Shares Acquired by Swiss National Bank at Defense World.
12 Feb 2024
Exelixis (EXEL) Loses -10.93% in 4 Weeks, Here's Why a Trend Reversal May be Around the Corner
The heavy selling pressure might have exhausted for Exelixis (EXEL) as it is technically in oversold territory now. In addition to this technical measure,...
WMC Market Score
WMC Market to Revenue Score
Exelixis, Inc. Market Financials
Revenue, Expenses, Profit
| Company | Currency | Revenue | Expense | Profit | Market Cap | WMC Sector Score |
| Exelixis, Inc. | USD | $1,030,853 | $938,028 | $64,770 | $62,290B | 15 |
| Regeneron Pharmaceuticals, Inc. | USD | $9,197,600 | $3,997,800 | $4,003,800 | $804,390B | 1 |
| Vertex Pharmaceuticals Incorporated | USD | $6,414,881 | $2,617,257 | $2,762,032 | $878,880B | 2 |
| Alexion Pharmaceuticals, Inc. | USD | $6,261,601 | $2,747,200 | $681,800 | $ 0.00 | 3 |
| ALK-Abello A/S | USD | $3,556,000 | $1,893,000 | $66,000 | $189,400B | 4 |
Market Analytics
Company Search vs Top 4 Industry Competitors
Total Exelixis, Inc. Social Followers vs Top 4 Industry Competitors
Exelixis, Inc. Post vs Top 4 Industry Competitors
Exelixis, Inc. Digital Footprint By Size vs Top 4 Industry Competitors
Exelixis, Inc. Digital Footprint By Change Rate vs Top 4 Industry Competitors
Exelixis, Inc. WMC Market Score Calculations
| Details | Revenue | Total Social Followers | Total Social Posts | Search Volume | Digital Footprint Size | Digital change (New Pages) | WMC Market Score |
| Exelixis, Inc. | 11.21 | 12.71 | 0.05 | 0 | 0 | 0 | 4.55 |
| Regeneron Pharmaceuticals, Inc. | 100 | 25.50 | 16.15 | 70 | 0 | 0 | 39.85 |
| Vertex Pharmaceuticals Incorporated | 69.75 | 35.68 | 8.95 | 100 | 0 | 0 | 51.56 |
| Alexion Pharmaceuticals, Inc. | 68.08 | 100 | 100 | 80 | 0 | 0 | 100 |
| ALK-Abello A/S | 38.66 | 0 | 0 | 0 | 0 | 0 | 0 |
Book a demo
Book a free one-on-one demo with one of our team and see exactly how the WMC business intelligence platform can help you protect and grow revenue.
* required fields
You'll learn how to:
- 1. Automatically monitor your entire digital landscape including competitors
- 2. View all new industry activity in real time
- 3. Monitor your position in your industry
- 4. Enrich your reports and strategy
- 5. Empower your teams with knowledge
